Website stats for Cerevance - cerevance.com
Cerevance is developing therapeutics that act on target proteins expressed highly selectively in brain cell types that die in disease, play a key role in the disease process, or are located in brain circuits disrupted by disease. In some cases, our NETSseq platform has revealed that a target protein is dysregulated in human disease tissue samples. We believe that advancing drugs that act on select...
cerevance.com was registered 8 years 4 months ago. It has a alexa rank of #7,929,179 in the world. It is a domain having .com extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, cerevance.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 111 |
| Daily Pageviews: | 222 |
Estimated Valuation
| Income Per Day: | $ 1.00 |
| Estimated Worth: | $ 240.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 7,929,179 |
| PageSpeed Score: | 82 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
160.153.92.197
Hosted Country:
US
Location Latitude:
33.602Location Longitude:
-111.888Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | 27.12% |
| Referral Traffic: | 0% |
| Search Traffic: | 72.88% |
| Social Traffic: | 0% |
| Mail Traffic: | 0% |
| Display Traffic: | 0% |
Search Engine Results For cerevance.com
Cerevance
We would like to show you a description here but the site won’t allow us.
Cerevance | LinkedIn
Cerevance’s focus on identifying new drug targets for central nervous system diseases using our proprietary NETSseq platform is featured in this PM360 Magazine Magazine article,...
Accueil du site du CEREVANCE
Ce site est dédié aux cytopénies auto-immunes de l’enfant, un ensemble de maladies auto-immunes du sang s'attaquant aux plaquettes sanguines (PTI/Purpura Thrombopénique...
Cerevance Closes $45 Million Series B Financing
Apr 14, 2020 · BOSTON, MA, April 14, 2020 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development company focused on brain diseases, has closed a Series B...
cerevance - pre-IPO Pharma
COMPANY OVERVIEW Cerevance is a new pharmaceutical company focused on central nervous system diseases. Their strengths include a powerful technology platform, a pipeline of...
Cerevance | VentureRadar
"Cerevance is a new pharmaceutical company focused on central nervous system diseases. Our strengths include a powerful technology platform, a pipeline of novel discovery-stage...
Cerevance Expands Series B Financing to $65 Million
Jul 21, 2020 · BOSTON, July 21, 2020 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development company focused on brain diseases, has expanded its Series B …
Cerevance Enters Research Collaboration with Takeda to ...
Dec 17, 2019 · Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, has formed a multi-year research alliance with Taked
Cerevance becomes latest investment from UPMC Enterprises ...
Sep 28, 2020 · After announcing a $1 billion commitment to life sciences startups earlier this year, UPMC Enterprises’ Translational Sciences team makes second external investment.
Cerevance - Cambridge Science Park
Cerevance is a new pharmaceutical company focused on central nervous system diseases. Our strengths include a powerful technology platform, a pipeline of novel discovery-stage...
Cerevance Company Profile - Office Locations, Competitors ...
Cerevance is a new pharmaceutical company focused on central nervous system diseases. The Company's strengths include a powerful technology platform, a pipeline of novel...
Cerevance , LLC - Overview, News & Competitors | ZoomInfo.com
View Cerevance , LLC (www.cerevance.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as …
Cerevance | LinkedIn
Cerevance | 816 followers on LinkedIn | Cerevance. In this Technology Networks article, our CEO Brad Margus discussed using our NETSseq platform to overcome challenges in...
Cerevance Company Profile: Valuation & Investors | PitchBook
Cerevance General Information Description. Developer of novel therapeutics intended to advance new medicines for serious neurological diseases. The company's therapeutics...
Life Science Leader - Home Page
Implementation Of MFN, Importation, And Other Mischief In 2020 As the election nears and a potential change in power of both the White House and Congress approaches, it is...
Study of CVN424 in Parkinson's Disease Patients With Motor ...
Dec 10, 2019 · Individual results of laboratory tests from hematology panels that are abnormal and clinically significant will be summarized and listed. Observed values and...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | 3 |
| H3 Headings: | 1 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 3 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-140650904-1 |
Mobile Friendly Check
Mobile Friendly : Unknown
Score : Unknown
No data to show.
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Thu, 18 Jul 2019 23:50:02 GMT
Server: Apache
X-Powered-By: PHP/7.2.19
X-Pingback: https://cerevance.com/xmlrpc.php
Link:
Upgrade: h2,h2c
Connection: Upgrade
Vary: Accept-Encoding,User-Agent
Content-Encoding: gzip
Content-Length: 5802
Content-Type: text/html; charset=UTF-8
Domain Information
| Domain Registrar: |
GoDaddy.com, LLC
|
|---|---|
| Registration Date: | 2015-12-10 8 years 4 months 2 weeks ago |
| Last Modified: | 2017-01-17 7 years 3 months 6 days ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns47.domaincontrol.com | |
97.74.103.24 | United States |
| ns48.domaincontrol.com | |
173.201.71.24 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| cerevance.com | A | 3584 |
IP: 160.153.92.197 |
| cerevance.com | NS | 3600 |
Target: ns48.domaincontrol.com |
| cerevance.com | NS | 3600 |
Target: ns47.domaincontrol.com |
| cerevance.com | SOA | 600 |
MNAME: ns47.domaincontrol.com RNAME: dns.jomax.net Serial: 2019052302 Refresh: 28800 Retry: 7200 Expire: 604800 |
| cerevance.com | MX | 3600 |
Target: cerevance-com.mail.protection.outlook.com |
| cerevance.com | TXT | 3600 |
TXT: v=spf1 include:spf.protection.outlook.com -all |
| cerevance.com | TXT | 3600 |
TXT: _globalsign-domain-verification=KFDijCU3 AjMN1tb2i-7xKdWYqypa-pDKOtCBn5iv0S |
| cerevance.com | TXT | 3600 |
TXT: _globalsign-domain-verification=_vg-xCoP 9IzHLWD-iDqauWKeIGp7EkBnz1ykmFoRhY |
Alexa Traffic Rank
Alexa Search Engine Traffic
Top Organic Keyword
| 1. | cerevance |
| 2. | envoy therapeutics |
| 3. | cerevance pipeline |
Top Paid Keyword
| Not Applicable |
Full WHOIS Lookup
Registry Domain ID:
1986510449_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2017-01-17T08:58:02Z
Creation Date:
2015-12-09T21:46:31Z
Registry Expiry Date:
2021-12-09T21:46:31Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS47.DOMAINCONTROL.COM
Name Server:
NS48.DOMAINCONTROL.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-07-18T23:50:13Z
Similarly Ranked Websites
Marlowe SLU is a pet-friendly apartment community in Seattle, WA.
Marlowe caters to tech connoisseurs, spirited entrepreneurs, and young professionals seeking a live-work-play balance in one of Seattle’s most desirable neighborhoods.
7,929,211 
$ 240.00
Adrenal Fatigue and Thyroid Care (AFTC) - Patient to Patient Care...
Patient to Patient Care and support for Adrenal Fatigue ~ Hypothyroidism ~ Hashimoto's ~ Gut Health
7,929,253 $ 240.00
首頁 - Primada
Primada 寶康達 自煮健康入廚樂 廚房家電 智能煲 養生機 烤焗寶 慢磨機 陶燒寶 生活家電 無線旋風吸塵機
7,929,284 $ 240.00